Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
2011-001403-12Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of carbogen in febrile seizure (FS), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Efficacy of carbogen inhalation. Started Oct 2011; status: terminated.
02
Drugs
carbogen
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on 2011-001403-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001403-12.